Epsilon M&A Deal Report - Laboratoire X.O

Transaction Multiples for the Valuation of Private Companies

Private Group led by Novalpina Capital > Laboratoire X.O

Announced Date : 10 November 2020

Type : LBO (Leverage Buy Out)

Deal Value : Yes

Acquirer : Private Group led by Novalpina Capital

Target Laboratoire X.O

Target Country France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Co-founded in 2015 by Karine Pinon and Gerard Leduc, Laboratoire X.O is a specialty pharmaceutical company that markets and sells a range of prescription and OTC drugs in France and internati ...

No EMAT : 102982

Transaction multiples available

EV/Sales EV/Gross Profit EV/EBITDA EV/EBIT Eq/PBT P/E Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date Acquirer Target Country Multiples See details
05/03/2019 Funding round led by Ouest Croissance, Unexo, Arkéa Capital Investment Nature et Stratégie France 0
24/10/2016 Technature Laboratoires Science et Mer France 0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe to EMAT database